Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells1
Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells1
复制标题
人 NKR-P1A 与其在活化树突细胞和 B 细胞上表达的配体 LLT1 之间相互作用的功能后果1
DOI:
--
复制
发表时间:
2008
影响因子:
4.4
通讯作者:
Lewis L. Lanier
中科院分区:
文献类型:
--
作者:
D. Rosen;W. Cao;D. Avery;S. Tangye;Yong‐jun Liu;J. P. Houchins;Lewis L. Lanier;Lewis L. Lanier
Lectin-like transcript-1 (LLT1) (also named osteoclast inhibitory lectin or CLEC2D) is a ligand for the human NKR-P1A (CD161) receptor, present on NK cells and T cells. To further understand the physiological relevance of this interaction, we developed mAbs against LLT1, characterized the expression pattern of LLT1, and explored the functional consequence of LLT1 engagement of the NKR-P1A receptor on NK cells and T cells. LLT1 is expressed on TLR-activated plasmacytoid dendritic, TLR-activated monocyte-derived dendritic cells, and on B cells stimulated through TLR9, surface Ig, or CD40. Interactions between NKR-P1A on NK cells and LLT1 on target cells inhibit NK cell-mediated cytotoxicity and cytokine production and can inhibit TNF-α production by TCR-activated NKR-P1A+ CD8+ T cells. In contrast, NKR-P1A failed to inhibit or augment the TCR-dependent activation of NKR-P1A-bearing CD4+ T cells. Expression of LLT1 on activated dendritic cells and B cells suggests that it might regulate the cross-talk between NK cells and APCs.
影响因子:
4.2
作者:
Kinsella, TM;Nolan, GP
通讯作者:
Nolan, GP
影响因子:
30.5
作者:
Welte, Stefan;Kuttruff, Sabrina;Steinle, Alexander
通讯作者:
Steinle, Alexander
影响因子:
20.3
作者:
Hanabuchi, S;Watanabe, N;Liu, YJ
通讯作者:
Liu, YJ